Skip to main content
Mathias Lichterfeld, MD, Infectious Disease, Boston, MA

Mathias Lichterfeld MD

Infectious Disease•Boston, MA

Infectious Disease Division Massachusetts General Hospital

Join to View Full Profile

  • 101 Nicolls RdBoston, MA 11794

  • Phone+1 617-724-6620

  • Fax+1 617-726-5411

Dr. Lichterfeld is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.
See Dr. Lichterfeld's Full ProfileAlready have an account?

Education & Training

  • Mass General Brigham/Massachusetts General Hospital/Brigham and Women's Hospital
    Mass General Brigham/Massachusetts General Hospital/Brigham and Women's HospitalFellowship, Infectious Disease, 2008 - 2010
  • Mass General Brigham/Massachusetts General Hospital
    Mass General Brigham/Massachusetts General HospitalResidency, Internal Medicine, 2006 - 2008
  • Mass General Brigham/Massachusetts General Hospital
    Mass General Brigham/Massachusetts General HospitalInternship, Internal Medicine, 2006 - 2007
  • University of Bonn Faculty of Medicine
    University of Bonn Faculty of MedicineClass of 2000

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 2008 - 2026
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Infectious Disease
    American Board of Internal Medicine Infectious Disease
  • Infectious Disease
    National Board of Physicians and Surgeons Infectious Disease
  • Internal Medicine
    National Board of Physicians and Surgeons Internal Medicine

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Single-Cell Studies Offer New View of How HIV Infections Persist—and Might Be Cured
    Single-Cell Studies Offer New View of How HIV Infections Persist—and Might Be CuredAugust 3rd, 2022
  • Mapping Where HIV Hides Its Genes Suggests Cure Strategy
    Mapping Where HIV Hides Its Genes Suggests Cure StrategyJanuary 12th, 2022
  • Researchers Identify New HIV Patient Who Appears to Have Been ‘Cured’ Without Treatment
    Researchers Identify New HIV Patient Who Appears to Have Been ‘Cured’ Without TreatmentNovember 19th, 2021
  • Join now to see all

Grant Support

  • Immune selection of HIV-1 reservoir cells in human clinical trialsBRIGHAM AND WOMEN'S HOSPITAL2024–2029
  • A Clinical Trial of Three Broadly Neutralizing Antibodies and Analytic Treatment Interruption in Early-Treated Children in BotswanaHARVARD SCHOOL OF PUBLIC HEALTH2023–2028
  • Single-cell Proteogenomic profiling of HIV-1 reservoir cellsBRIGHAM AND WOMEN'S HOSPITAL2023–2028
  • A Clinical Trial of Three Broadly Neutralizing Antibodies and Analytic Treatment Interruption in Early-Treated Children in BotswanaHARVARD SCHOOL OF PUBLIC HEALTH2023–2028
  • A Clinical Trial of Three Broadly Neutralizing Antibodies and Analytic Treatment Interruption in Early-Treated Children in BotswanaHARVARD SCHOOL OF PUBLIC HEALTH2023–2028
  • A Clinical Trial of Three Broadly Neutralizing Antibodies and Analytic Treatment Interruption in Early-Treated Children in BotswanaHARVARD SCHOOL OF PUBLIC HEALTH2023–2028
  • A Clinical Trial of Three Broadly Neutralizing Antibodies and Analytic Treatment Interruption in Early-Treated Children in BotswanaHARVARD SCHOOL OF PUBLIC HEALTH2023–2028
  • A Clinical Trial of Three Broadly Neutralizing Antibodies and Analytic Treatment Interruption in Early-Treated Children in BotswanaHARVARD SCHOOL OF PUBLIC HEALTH2023–2028
  • A Clinical Trial of Three Broadly Neutralizing Antibodies and Analytic Treatment Interruption in Early-Treated Children in BotswanaHARVARD SCHOOL OF PUBLIC HEALTH2023–2028
  • Mentoring in patient-oriented research to finding a cure for HIV-1 infectionBRIGHAM AND WOMEN'S HOSPITAL2021–2026
  • Mentoring in patient-oriented research to finding a cure for HIV-1 infectionBRIGHAM AND WOMEN'S HOSPITAL2021–2026
  • Mentoring in patient-oriented research to finding a cure for HIV-1 infectionBRIGHAM AND WOMEN'S HOSPITAL2021–2026
  • Mentoring in patient-oriented research to finding a cure for HIV-1 infectionBRIGHAM AND WOMEN'S HOSPITAL2021–2026
  • Mentoring in patient-oriented research to finding a cure for HIV-1 infectionBRIGHAM AND WOMEN'S HOSPITAL2021–2026
  • Selection and Evolution of HIV-1 reservoir cells in blood and tissuesBRIGHAM AND WOMEN'S HOSPITAL2020–2026
  • Selection and Evolution of HIV-1 reservoir cells in blood and tissuesBRIGHAM AND WOMEN'S HOSPITAL2020–2026
  • Selection and Evolution of HIV-1 reservoir cells in blood and tissuesBRIGHAM AND WOMEN'S HOSPITAL2020–2026
  • Selection and Evolution of HIV-1 reservoir cells in blood and tissuesBRIGHAM AND WOMEN'S HOSPITAL2020–2026
  • Selection and Evolution of HIV-1 reservoir cells in blood and tissuesBRIGHAM AND WOMEN'S HOSPITAL2020–2026
  • Novel single genome approaches to determine the mechanisms of HIV latent infection in blood, gut, and lymph nodesNORTHERN CALIFORNIA INSTITUTE/RES/EDU2019–2025
  • Molecular profile of proviral reservoirs in HIV-infected drug usersMASSACHUSETTS GENERAL HOSPITAL2018–2025
  • A clinical trial to evaluate the impact of broadly neutralizing antibody VRC01 on HIV viral reservoir and maintenance of suppression in a cohort of early-treated children in BotswanaHARVARD SCHOOL OF PUBLIC HEALTH2018–2025
  • Molecular profile of proviral reservoirs in HIV-infected drug usersMASSACHUSETTS GENERAL HOSPITAL2018–2025
  • Molecular profile of proviral reservoirs in HIV-infected drug usersMASSACHUSETTS GENERAL HOSPITAL2018–2025
  • Molecular profile of proviral reservoirs in HIV-infected drug usersMASSACHUSETTS GENERAL HOSPITAL2018–2025
  • Molecular profile of proviral reservoirs in HIV-infected drug usersMASSACHUSETTS GENERAL HOSPITAL2018–2025
  • Limiting HIV-1 persistence by targeting stem cell properties of cellular immune memoryNational Institute of Allergy and Infectious Diseases (NIAID)2013–Present
  • Innate Resistance Of CD4 T Cells To HIV-1 Infection In Elite ControllersNational Institute Of Allergy And Infectious Diseases2011–2012

Professional Memberships

Other Languages

  • German

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence:

Dr. Mathias Lichterfeld, Dr. Mathias Lichterfeld, MD, Dr. M Lichterfeld